| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.66B | +15.6% |
| Cost of Revenue | $1.86B | +16.6% |
| Gross Profit | $2.80B | +14.9% |
| R&D Expense | $599.1M | +8.5% |
| SG&A Expense | $1.29B | +0.4% |
| Operating Income | $911.8M | +52.0% |
| Interest Expense | $14.3M | -4.0% |
| Pre-tax Income | $1.09B | +53.5% |
| Income Tax | $252.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $917.7M | +51.4% |
| Accounts Receivable | $1.22B | +20.9% |
| Inventory | $629.1M | +15.9% |
| Current Assets | $4.03B | -6.2% |
| Total Assets | $6.34B | -2.2% |
| Current Liabilities | $2.14B | -26.9% |
| Total Liabilities | $3.59B | -18.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.44B | +45.6% |
| Capital Expenditures | $363.5M | +1.3% |
| Investing Cash Flow | $536.0M | +358.3% |
| Financing Cash Flow | -$1.69B | -129.5% |
| Free Cash Flow | $1.08B | +70.8% |
| +89.8% |
| Net Income | $836.3M | +45.1% |
| EPS (Basic) | $2.14 | +46.6% |
| EPS (Diluted) | $2.09 | +47.2% |
| Stockholders' Equity |
| $2.75B |
| +30.6% |